PureTech Health plc (PRTC)
NASDAQ: PRTC · IEX Real-Time Price · USD
22.10
-0.05 (-0.23%)
At close: Jul 19, 2024, 4:00 PM
21.36
-0.74 (-3.35%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
PureTech Health Revenue
In the year 2023, PureTech Health had annual revenue of $3.33M.
Revenue (ttm)
$3.33M
Revenue Growth
-78.68%
P/S Ratio
158.83
Revenue / Employee
$37,000
Employees
90
Market Cap
528.89M USD
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 3.33M | -12.29M | -78.68% |
| Dec 31, 2022 | 15.62M | -1.77M | -10.18% |
| Dec 31, 2021 | 17.39M | 5.62M | 47.76% |
| Dec 31, 2020 | 11.77M | 1.96M | 20.00% |
| Dec 31, 2019 | 9.81M | -10.94M | -52.73% |
| Dec 31, 2018 | 20.75M | 18.21M | 718.46% |
| Dec 31, 2017 | 2.54M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Community Health Systems | 12.52B |
| Cross Country Healthcare | 1.78B |
| Canopy Growth | 218.49M |
| Valneva SE | 166.26M |
| Y-mAbs Therapeutics | 84.50M |
| Contineum Therapeutics | 50.00M |
| OmniAb | 21.05M |
PRTC News
- 4 weeks ago - PureTech Health: Results of the Tender Offer - Business Wire
- 4 weeks ago - PureTech Announces Change of Board Role - Business Wire
- 4 weeks ago - PureTech Founded Entity Seaport Therapeutics Appoints Seasoned Executives to Management Team - Business Wire
- 5 weeks ago - PureTech Health: Results of Annual General Meeting - Business Wire
- 6 weeks ago - PureTech Health: Result of General Meeting - Business Wire
- 7 weeks ago - PureTech Founded Entity Akili Interactive and Virtual Therapeutics Announce Entering Into Definitive Merger Agreement to Establish Leading Digital Health Company - Business Wire
- 2 months ago - PureTech to Present at the Jefferies Global Healthcare Conference - Business Wire
- 2 months ago - PureTech Founded Entity Vedanta Biosciences Enrolls First Patient in Pivotal Phase 3 RESTORATiVE303 Study of VE303 for the Prevention of Recurrent C. difficile Infection - Business Wire